July 18, 2018
Willkie acted for the creditors in relation to a €65 million cov-lite second lien facility backing Astorg’s acquisition of Dutch group IGM Resins from Arsenal Capital Partners.
Willkie recently acted for the creditors in relation to a €65 million cov-lite second lien facility backing Astorg’s acquisition of Dutch group IGM Resins from Arsenal Capital Partners. IGM specializes in the development, manufacture and supply of products and technical services to the global UV coatings and inks market. IGM develops, produces and distributes a full range of radiation curable materials, including photoinitiators, acrylate oligomers and monomers and additives from manufacturing facilities in Europe, Asia, and the US, supported by technical labs in each of these regions to help create next generation energy curable coatings and inks.
The financing also included a €260 million first lien facility and €50 million RCF. The transaction closed on July 3, 2018.
The Willkie team was led by partner Mark Fine and included associates Aymen Mahmoud and Nick Jupp.